MedTravest IV ApS
CVR 44303981 · Private limited company (ApS) · Active · Low risk
MedTravest IV ApS is a Private limited company (ApS), founded on , based in Grindsted. The company is registered in the industry ikke-finansielle holdingselskaber. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 2 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 45.1m and a net result of DKK -17k. CEO: Charlotte Vindfeldt.
Bankruptcy risk for MedTravest IV ApS
0.0 × the average (1.41%) · higher risk than 18% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 44303981
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (3 years)
- Address
- Lundhedevej 25A
7200 Grindsted - Municipality
- Billund
- Industry
- Ikke-finansielle holdingselskaber (642120)
Bankruptcies in the industry: Ikke-finansielle holdingselskaber - Share capital
- DKK 64.4m
- Auditor
- PricewaterhouseCoopersStatsautoriseret Revisionspartnerselskab
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 2 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 99.9% |
| Current ratio | 9,240% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 2 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 23 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK -27k | DKK -25k |
| Net profit | DKK -17k | DKK -20k |
| Equity | DKK 45.1m | DKK 26.5m |
| Total assets | DKK 45.2m | DKK 26.5m |
| Cash | DKK 3.4m | – |
| Short-term debt | DKK 37k | DKK 25k |
| Avg. employees | 0 | 0 |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · PricewaterhouseCoopersStatsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 77 | ||
| 15 Sep 2023 – 31 Dec 2024 | 78 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Charlotte Vindfeldt | Current | |
| CEO | Peter Juul Kristensen | ||
| Board | Martin Lund Madsen | Current | |
| Board | Jonas Koch Nørgaard | Current | |
| Board | Charlotte Vindfeldt | Current | |
| Board | Peter Juul Kristensen | ||
| Owner (5%) | Hyorakel Invest ApS | Current | |
| Owner (5%) | ACCAN ApS | Current | |
| Owner (67%) | MSF Family Invest A/S | Current | |
| Owner (5%) | KOCH NØRGAARD HOLDING ApS | Current | |
| Owner (100%) | KOCH NØRGAARD HOLDING ApS | ||
| Owner (5%) | ACCAN ApS | ||
| Owner (67%) | MLM Group A/S | ||
| Owner (10%) | ACCAN ApS | ||
| Owner (5%) | KOCH NØRGAARD HOLDING ApS | ||
| Owner (50%) | MLM Group A/S | ||
| Owner (15%) | MSF Family Invest A/S | ||
| Founder | KOCH NØRGAARD HOLDING ApS | Current |
The CEOs' other companies
Charlotte Vindfeldt – 11 other companies
- Bioenergiselskabet af 17. januar 2024 Komplementarselskab ApS Active
- CHV Group ApS Active
- FHM Slagtegrise A/S Active
- Grusgrav.dk ApS Active
- MSF Family Invest A/S Active
- MedTrace Pharma A/S Active
- My Wine Consulting ApS Active
- Ny Endrupholm Nord A/S Active
- Precision Antibiotics ApS Active
- SLOVAKIET INVEST A/S Opløst
- Vognmandsfirmaet Flemming Paulsen A/S Active
Peter Juul Kristensen – 13 other companies
- AKSET A/S Active
- CAMILLA E. RASMUSSEN HOLDING ApS Active
- DYRLÆGE PRAKSIS ApS Opløst
- JUUL KRISTENSEN HOLDING ApS Active
- Lerche-Simonsen ApS Opløst
- MedTrace Pharma A/S Active
- MedTravest A/S Active
- MedTravest II ApS Active
- Medtravest III ApS Active
- Precision Antibiotics ApS Active
- SLOVAKIAN FARM INVEST A/S Active
- SLOVAKIET INVEST A/S Opløst
- Synomics ApS Opløst
Address history (1 moves)
| Lundhedevej 25A, 7200 Grindsted | |
| Søvejen 13, 8752 Østbirk |
Other companies at the same address
- URUP-NYGÅRD LANDBRUG A/S Bankrupt
- BAKKEBO LANDBRUG ApS Active
- CHV Group ApS Active
- FHM Group ApS Active
- FHM Slagtegrise A/S Active
- JÆGERGÅRDEN LANDBRUG ApS Fusioneret
- KAROLINESYNDE ApS Fusioneret
- MLM GROUP A/S Fusioneret
- MLM Group A/S Active
- MLM Interim ApS Fusioneret
- MSF Family Invest A/S Active
- MSF Group ApS Active
- MSF Poultry ApS Active
- My Wine Consulting ApS Active
- NY ENDRUPHOLM A/S Active
- NY ENDRUPHOLM INVEST ApS Active
- NY SOLVANG ApS Active
- NY STENTOFT ApS Active
- NY VESTERGAARD ApS Active
- Ny Damgård ApS Active
- Ny Endrupholm Nord A/S Active
- Ny Midtgård ApS Active
- SHM Group ApS Active
Similar companies in Billund
- Vanguard Invest I ApS Billund
- Holm Hein Holding ApS Grindsted
- Mejer Invest ApS Billund
- Alero Holding ApS Billund
- K. Garlik Holding ApS Billund
- Wohlk Holding ApS Billund
- Raun Andersen Holding ApS Vorbasse
- FIMO Holding ApS Billund
- Elbæk Østergaard Holding ApS Grindsted
- Bo Ingenuus Jørgensen ApS Grindsted
- NSJ Holding 2026 ApS Billund
- KL-Hedevang ApS Hejnsvig
Questions and answers about MedTravest IV ApS
Has MedTravest IV ApS gone bankrupt?
No, MedTravest IV ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of MedTravest IV ApS?
Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of MedTravest IV ApS?
Charlotte Vindfeldt is the CEO of MedTravest IV ApS.
Who is the auditor of MedTravest IV ApS?
MedTravest IV ApS most recently used PricewaterhouseCoopersStatsautoriseret Revisionspartnerselskab.
When was MedTravest IV ApS founded?
MedTravest IV ApS was founded on 15 September 2023.
What is the equity of MedTravest IV ApS?
Equity was DKK 45.1m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.